Nothing Special   »   [go: up one dir, main page]

DK0943326T4 - Pulveragtigt præparat til nasal administration - Google Patents

Pulveragtigt præparat til nasal administration

Info

Publication number
DK0943326T4
DK0943326T4 DK97905398T DK97905398T DK0943326T4 DK 0943326 T4 DK0943326 T4 DK 0943326T4 DK 97905398 T DK97905398 T DK 97905398T DK 97905398 T DK97905398 T DK 97905398T DK 0943326 T4 DK0943326 T4 DK 0943326T4
Authority
DK
Denmark
Prior art keywords
water
absorbing
base material
drug
gel
Prior art date
Application number
DK97905398T
Other languages
English (en)
Other versions
DK0943326T3 (da
Inventor
Masahiko Dohi
Yoshihisa Nishibe
Yuji Makino
Takao Fujii
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26378964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0943326(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of DK0943326T3 publication Critical patent/DK0943326T3/da
Application granted granted Critical
Publication of DK0943326T4 publication Critical patent/DK0943326T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97905398T 1996-02-27 1997-02-26 Pulveragtigt præparat til nasal administration DK0943326T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3955396 1996-02-27
JP4107996 1996-02-28
PCT/JP1997/000541 WO1997031626A1 (fr) 1996-02-27 1997-02-26 Composition pulverulente destinee a une adminstration nasale

Publications (2)

Publication Number Publication Date
DK0943326T3 DK0943326T3 (da) 2003-12-08
DK0943326T4 true DK0943326T4 (da) 2007-01-22

Family

ID=26378964

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97905398T DK0943326T4 (da) 1996-02-27 1997-02-26 Pulveragtigt præparat til nasal administration

Country Status (13)

Country Link
US (3) US6881423B2 (da)
EP (1) EP0943326B2 (da)
JP (1) JP3634380B2 (da)
KR (1) KR100568436B1 (da)
CN (1) CN1155368C (da)
AT (1) ATE247456T1 (da)
AU (1) AU722319B2 (da)
CA (1) CA2247191C (da)
DE (1) DE69724272T3 (da)
DK (1) DK0943326T4 (da)
ES (1) ES2205177T5 (da)
PT (1) PT943326E (da)
WO (1) WO1997031626A1 (da)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0943326T4 (da) * 1996-02-27 2007-01-22 Teijin Ltd Pulveragtigt præparat til nasal administration
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
EP1025859B1 (en) * 1998-08-26 2006-06-28 Teijin Limited Powdery pernasal compositions
ES2252993T3 (es) * 1998-12-09 2006-05-16 Chiron Corporation Administracion de agentes neurotroficos al sistema nervioso central.
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AU2002218503B2 (en) * 2000-11-29 2006-09-28 Ils Inc. Powdery preparations and methods for producing the same
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
US6906027B2 (en) 2001-07-05 2005-06-14 Translational Research Ltd. Composition for nasal administration of insulin
CA2468250A1 (en) * 2001-11-26 2003-06-05 Daiichi Suntory Pharma Co., Ltd. Pharmaceutical composition for nasal absorption
ES2425392T3 (es) 2002-03-20 2013-10-15 Mannkind Corporation Cartucho para un aparato de inhalación
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20080260838A1 (en) * 2003-08-01 2008-10-23 Mannkind Corporation Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
US7714011B2 (en) * 2002-09-13 2010-05-11 Zicam, Llc Compositions to reduce congestion and methods for application thereof to the nasal membrane
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
WO2004084859A2 (en) 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
CN1758930B (zh) 2003-03-27 2010-06-09 株式会社新日本科学 鼻腔用粉末药剂喷药装置
GB0315632D0 (en) 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
JP4922762B2 (ja) * 2004-08-10 2012-04-25 株式会社新日本科学 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
US7820676B2 (en) 2004-08-23 2010-10-26 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US7115561B2 (en) * 2004-09-22 2006-10-03 Patterson James A Medicament composition and method of administration
GB2420707A (en) * 2004-10-11 2006-06-07 Nasaleze Patents Ltd Compositions for intranasal administration
US8202550B2 (en) 2004-10-11 2012-06-19 Nasaleze Ppm Limited Compositions for intranasal administration
PL1824450T3 (pl) * 2004-10-11 2013-04-30 Nasaleze Patents Ltd Kompozycje do podawania donosowego
WO2007022345A2 (en) * 2005-08-17 2007-02-22 Fleming And Company, Pharmaceuticals Vitamin b12 nasal spray and method of use
EP2056800B1 (en) 2005-08-26 2015-12-09 The Board Of Trustees Of The Leland Stanford Junior University Therapy procedure for drug delivery for trigeminal pain
ES2640282T3 (es) 2005-09-14 2017-11-02 Mannkind Corporation Método de formulación de fármacos basado en el aumento de la afinidad de superficies de micropartículas cristalinas para agentes activos
CA2643464C (en) 2006-02-22 2018-09-04 Mannkind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
CN101668544B (zh) 2006-12-26 2013-04-24 株式会社新日本科学 经鼻投用制剂
AU2008316634B2 (en) * 2007-10-24 2014-02-27 Mannkind Corporation Method of preventing adverse effects by GLP-1
WO2011163272A1 (en) 2010-06-21 2011-12-29 Mannkind Corporation Dry powder drug delivery system and methods
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
IL279542B2 (en) 2008-06-13 2023-10-01 Mannkind Corp Dry powder inhaler and drug delivery system
EP2300083B1 (en) 2008-06-20 2013-05-22 MannKind Corporation An interactive apparatus and method for real-time profiling of inhalation efforts
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
PL2405963T3 (pl) 2009-03-11 2014-04-30 Mannkind Corp Urządzenie, układ i sposób pomiaru oporu inhalatora
WO2010131486A1 (en) * 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
AU2010259943C1 (en) 2009-06-12 2016-03-03 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
WO2011013003A2 (en) * 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
ES2533987T3 (es) * 2009-09-02 2015-04-16 Nippon Soda Co., Ltd. Partículas de hidroxipropil celulosa
EP2298286B8 (en) * 2009-09-18 2017-08-09 SiTec PharmaBio SL Process for dewatering of product powders
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
EP2548566B1 (en) 2010-03-19 2018-02-21 Daiichi Sankyo Company, Limited Composition for transnasal administration and method for producing same
SG194034A1 (en) 2011-04-01 2013-11-29 Mannkind Corp Blister package for pharmaceutical cartridges
SE536091C2 (sv) 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
AR086400A1 (es) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
MX2014004983A (es) 2011-10-24 2014-09-22 Mannkid Corp Metodos y composiciones para tratar dolor.
JP5717658B2 (ja) * 2012-01-13 2015-05-13 シスメックス株式会社 副腎皮質刺激ホルモンの検出方法および吸着剤
US9789071B2 (en) 2012-06-27 2017-10-17 G2B Pharma, Inc. Intranasal formulation of epinephrine for the treatment of anaphylaxis
ES2624294T3 (es) 2012-07-12 2017-07-13 Mannkind Corporation Sistemas de suministro de fármacos en polvo seco
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
HUE050050T2 (hu) 2013-03-04 2020-11-30 Besins Healthcare Lu Sarl Hordozórészecskékhez kötõdõ hatóanyag nanorészecskéket tartalmazó száraz gyógyászati kompozíciók
KR102499439B1 (ko) 2013-03-15 2023-02-13 맨카인드 코포레이션 미세결정성 디케토피페라진 조성물 및 방법
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
KR102465025B1 (ko) 2013-07-18 2022-11-09 맨카인드 코포레이션 열-안정성 건조 분말 약제학적 조성물 및 방법
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
EP3041461A4 (en) * 2013-09-03 2017-05-03 G2B Pharma Inc. Intranasal formulation for the treatment of cardiopulmonary resuscitation (cpr), cardiac life support (cls), anaphylaxis and/or anaphylactoid reactions
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
PT3242676T (pt) 2015-01-07 2023-12-06 TONIX Pharmaceuticals Holding Corp Formulações de ocitocina que contém magnésio e métodos de uso
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
KR20200092985A (ko) * 2017-11-27 2020-08-04 아스카 세이야쿠 가부시키가이샤 분말 경비 투여 제제
CN108158978A (zh) * 2018-03-26 2018-06-15 厦门传福堂药业有限公司 一种高分子水性凝胶及其制备方法和用途
CN113784703A (zh) * 2019-05-16 2021-12-10 株式会社新日本科学 经鼻施予用粉末制剂及其制造方法
WO2022132018A1 (en) * 2020-12-16 2022-06-23 Liw Innovation Ab A new powder composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS607965B2 (ja) * 1980-08-07 1985-02-28 帝人株式会社 鼻腔粘膜投与用粉剤の製造法
JPS59163313A (ja) 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
EP0187433B1 (en) * 1983-08-01 1990-12-27 Teijin Limited Powdery pharmaceutical composition suitable for application to mucosa of oral or nasal cavity
JPS6032714A (ja) * 1983-08-01 1985-02-19 Teijin Ltd 鼻腔粘膜に適用するための安定化された粉末状薬学的組成物
JPS6034925A (ja) 1983-08-04 1985-02-22 Mitsubishi Chem Ind Ltd ２−ヒドロキシイソフタルアルデヒド類の製造法
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
JPS6242888A (ja) 1985-08-21 1987-02-24 カシオ計算機株式会社 太陽電池を備えたｉｃカ−ド
GB2193891B (en) 1986-08-18 1990-07-25 Sandoz Ltd Nasal pharmaceutical composition containing a somatostatin anologue.
JP3068924B2 (ja) 1990-11-29 2000-07-24 旭硝子株式会社 熱線遮断膜
ATE158172T1 (de) * 1992-05-26 1997-10-15 Procter & Gamble Pulverförmige pharmazeutische zusammensetzung
DE69330672T2 (de) * 1992-06-12 2002-06-27 Teijin Ltd., Osaka Pharmazeutische zubereitung zur anwendung in den atemwegen
ES2171459T3 (es) * 1993-07-30 2002-09-16 Teijin Ltd Polvo para administracion nasal de farmaco peptidico o proteinaceo.
JPH07242550A (ja) 1994-03-02 1995-09-19 Teijin Ltd 二次性副甲状腺機能亢進症治療剤
DK0943326T4 (da) * 1996-02-27 2007-01-22 Teijin Ltd Pulveragtigt præparat til nasal administration

Also Published As

Publication number Publication date
US20020012688A1 (en) 2002-01-31
JP3634380B2 (ja) 2005-03-30
EP0943326A4 (en) 2000-12-20
WO1997031626A1 (fr) 1997-09-04
AU722319B2 (en) 2000-07-27
DE69724272T2 (de) 2004-06-09
US7731990B2 (en) 2010-06-08
PT943326E (pt) 2003-12-31
US6881423B2 (en) 2005-04-19
AU2230297A (en) 1997-09-16
KR100568436B1 (ko) 2007-04-25
DE69724272D1 (de) 2003-09-25
ES2205177T5 (es) 2007-08-01
DE69724272T3 (de) 2007-05-10
ES2205177T3 (es) 2004-05-01
US20040219108A1 (en) 2004-11-04
CN1155368C (zh) 2004-06-30
CN1216464A (zh) 1999-05-12
ATE247456T1 (de) 2003-09-15
US8206748B2 (en) 2012-06-26
EP0943326B2 (en) 2006-12-20
EP0943326B1 (en) 2003-08-20
KR19990087261A (ko) 1999-12-15
EP0943326A1 (en) 1999-09-22
CA2247191A1 (en) 1997-09-04
DK0943326T3 (da) 2003-12-08
CA2247191C (en) 2005-01-04
US20100047206A1 (en) 2010-02-25

Similar Documents

Publication Publication Date Title
DK0943326T4 (da) Pulveragtigt præparat til nasal administration
KR880700668A (ko) 특정 생체조직 부위로의 전달을 위한 아미노산 킬레이트의 조성물
KR890004686A (ko) 서방성 에토돌락
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
ATE75945T1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
DK0921812T3 (da) Insulinpræparater, som indeholder NaCi
KR920019371A (ko) 안정화된 인자 ⅷ 제제
KR890003400A (ko) 경비(經鼻)투여용 생리 활성 펩티드 분말 조성물(제제)
NO853075L (no) Fremgangsmaate for fremstilling av s-adenosyl-l-metionin (sam) salter.
DK0573551T3 (da) Serinrige peptidlinkere
IL140848A (en) Pharmaceutical compositions containing phenylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate
AU653371B2 (en) Pharmaceutical compositions
EP0825197A3 (en) New 6-hydroxy and 6-oxo-anstro-stane derivatives active on the cardiovascular system and pharmaceutical compositions containing same
NO913118L (no) T-pa pro stabilisering.
KR930012023A (ko) 환원된 형태의 비글리코실화 재조합 인체 il2의 안정화된 제약 조성물 및 그의 제조방법
DE68908958D1 (de) Peptide.
IT1314204B1 (it) Complessi di rutenio con elevata attivita' antitumorale